The added value of integrative medicine
Prof Alwin Krämer presents at ecancer's Milan Summit on Precision Medicine 2018 about cancers of unknown primary (CUP), where the initial tumour of a metastasised cancer cannot be identified.
He outlines the few data available on CUP syndrome, with some insight on an upcoming genomic based clinic trial surrounding CUP.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine
The added value of integrative medicine
Addressing Breast Cancer Disparities in Africa
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Social determinants of health in primary care